Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Rate of infections in dupilumab for atopic dermatitis compared with placebo∗
| Infections, overall, No. (%) |
URTI, No. (%) |
Nasopharyngitis, No. (%) |
|||
|---|---|---|---|---|---|
| Dupilumab | Placebo | Dupilumab | Placebo | Dupilumab | Placebo |
| 516 (41) | 321 (41) | 87 (6) | 42 (5) | 172 (13) | 100 (13) |
URTI, Upper respiratory tract infection.
These data are a combined average of three phase III trials. The dupilumab group is a combined average of two treatment schedules (once per week or once per two weeks).
